Characteristics of Patients with Early Rheumatoid Arthritis Who Have a Delayed Response to Treatment with Methotrexate in Monotherapy or in Combination with Adalimumab

被引：0
作者：
Smolen, Josef S. [1 ]
Bu, Xianwei [2 ]
Wang, Xin [2 ]
Suboticki, Jessica L. [3 ]
Kavanaugh, Arthur [4 ]
机构：
[1] Med Univ Vienna, Div Rheumatol, Dept Internal Med 3, Vienna, Austria
[2] AbbVie Inc, N Chicago, IL USA
[3] AbbVie Inc, Mettawa, IL USA
[4] Univ Calif San Diego, Med, La Jolla, CA 92093 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1419
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab
    Ornetti, P
    Solau, E
    Gaudin, P
    Sibilia, J
    Berthelot, JM
    Puechal, X
    Tavernier, C
    Maillefert, JF
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (09) : 1379 - 1380
  • [22] Beyond methotrexate monotherapy for early rheumatoid arthritis
    Scott, David L.
    LANCET, 2016, 388 (10042) : 309 - 310
  • [23] Treating Rheumatoid Arthritis to Target: Outcomes and Predictors in Early Rheumatoid Arthritis Patients Treated with Adalimumab Plus Methotrexate, Methotrexate Alone, or Methotrexate Plus Subsequent Adalimumab
    Smolen, Josef
    Fleischmann, Roy M.
    Emery, Paul
    van Vollenhoven, Ronald F.
    Guerette, Benoit
    Santra, Sourav
    Kupper, Hartmut
    Redden, Laura
    Wolfe, Benjamin
    Kavanaugh, Arthur
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S665 - S665
  • [24] Adalimumab and methotrexate combination could improve disease control for early-stage rheumatoid arthritis patients
    不详
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (04) : 408 - 408
  • [25] Adalimumab and methotrexate combination could improve disease control for early-stage rheumatoid arthritis patients
    不详
    IMMUNOTHERAPY, 2011, 3 (08) : 924 - 924
  • [26] TREATING RHEUMATOID ARTHRITIS TO TARGET: OUTCOMES AND PREDICTORS IN EARLY RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ADALIMUMAB PLUS METHOTREXATE, METHOTREXATE ALONE OR METHOTREXATE PLUS SUBSEQUENT ADALIMUMAB
    Smolen, Josef S.
    Fleischmann, Roy M.
    Emery, Paul
    van Vollenhoven, Ronald F.
    Guerette, Benoit
    Santra, Sourav
    Kupper, Hartmut
    Redden, Laura
    Kavanaugh, Arthur
    RHEUMATOLOGY, 2012, 51 : 114 - 115
  • [27] The combination glucocorticoid-adalimumab-methotrexate as induction therapy in early aggressive rheumatoid arthritis
    Montecucco, Carlomaurizio
    Caporali, Roberto
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (05) : 829 - 829
  • [28] Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis
    Burmester, Gerd R.
    Bykerk, Vivian P.
    Buch, Maya H.
    Tanaka, Yoshiya
    Kameda, Hideto
    Praestgaard, Amy
    van Hoogstraten, Hubert
    Fernandez-Nebro, Antonio
    Huizinga, Thomas
    RHEUMATOLOGY, 2022, 61 (06) : 2596 - 2602
  • [29] Predicting the Need for Additional Treatment in Early Rheumatoid Arthritis Patients Treated to Target on Methotrexate Monotherapy
    Teitsma, Xavier
    Jacobs, Johannes
    Welsing, Paco
    Woodworth, Thasia
    Petho-Schramm, Attila
    Borm, Michelle
    Bernasconi, Corrado
    Lafeber, Floris
    Bijlsma, Johannes W. J.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [30] Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the HOPEFUL-2 study
    Tanaka, Yoshiya
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Miyasaka, Nobuyuki
    Kawana, Katsuyoshi
    Hiramatsu, Katsutoshi
    Takeuchi, Tsutomu
    RMD OPEN, 2016, 2 (01):
12345